Hong Kong Interactive Media and Services Stock News

Sinotruk (Hong Kong) (SEHK:3808) has drawn fresh attention after reporting full year 2025 results, with sales of CNY 109,540.89 million and net income of CNY 7,019.3 million compared with the prior year. See our latest analysis for Sinotruk (Hong Kong). The full year 2025 report has arrived alongside brisk trading, with the share price at HK$39.82 after a 1-day share price return of 1.32% and a 7-day share price return of 4.96%. This is set against a 30-day share price return of negative...

Consun Pharmaceutical Group (SEHK:1681) opened FY 2025 with first half revenue of C¥1.57b and basic EPS of C¥0.59, set against trailing twelve month revenue of C¥3.42b and EPS of C¥1.27 that reflect earnings growth of 18.4% over the past year. The company has seen revenue move from C¥2.97b to C¥3.42b on a trailing basis, while EPS has gone from C¥1.11 to C¥1.27, supported by a trailing net profit margin of 31.5% that edges above last year’s 30.7%. This keeps profitability squarely in focus...

Why the latest earnings and dividend plan matter for investors China Construction Bank (SEHK:939) has put fresh numbers on the table, with its full year 2025 earnings and a proposed profit distribution plan that includes a defined 30% cash dividend payout ratio. See our latest analysis for China Construction Bank. The latest 2025 earnings update and confirmed 30% payout plan come after a period where the shares have gained 7.01% on a 90 day share price return and delivered a 28.03% 1 year...

HBM Holdings (SEHK:2142) is back in focus after Harbour BioMed reported positive first in human Phase I data for HBM9378, a TSLP targeting antibody, along with new regulatory milestones and an expanded global licensing arrangement. See our latest analysis for HBM Holdings. Those trial results appear to have reignited interest in the shares, with a 1 day share price return of 6.22% lifting HBM Holdings to HK$12.64 and adding to a 1 year total shareholder return of 37.69%. The 3 year total...

Wasion Holdings (SEHK:3393) has reported its FY 2025 results with first half revenue of C¥4.4b and basic EPS of C¥0.44, while trailing twelve month revenue stands at C¥10.1b with EPS of C¥1.07 on the same basis. The company has seen revenue move from C¥3.7b and EPS of C¥0.33 in the first half of FY 2024 to C¥5.0b and EPS of C¥0.38 in the second half, and then to C¥4.4b and EPS of C¥0.44 in the first half of FY 2025. This provides a clear view of how the top line and per share earnings have...

Recent share performance and business context Haidilao International Holding (SEHK:6862) has drawn attention after a 4.9% move over the past day, set against weaker returns over the past week, month and past 3 months for shareholders. For context, the company runs Haidilao branded hot pot restaurants and related delivery and condiment businesses across Mainland China, Hong Kong, Macau and Taiwan, supported by hotel, property and trading activities. See our latest analysis for Haidilao...

KLN Logistics Group event context and recent share performance KLN Logistics Group (SEHK:636) has attracted fresh attention after its recent name change from Kerry Logistics Network Limited. The move highlights its broad logistics footprint while the share price remains weaker over the month and past 3 months. See our latest analysis for KLN Logistics Group. At a share price of HK$6.63, KLN Logistics Group has seen weaker short term share price momentum, with a 30 day share price return of...

CNOOC (SEHK:883) has wrapped up FY 2025 with fourth quarter revenue of CNY 85.7b and basic EPS of CNY 0.43, alongside net income of CNY 20.1b. This sits against a trailing twelve month picture that includes revenue of CNY 398.2b and EPS of CNY 2.57. Over recent periods, revenue has ranged from CNY 106.9b in the first quarter of 2025 to CNY 85.7b in the fourth quarter, while quarterly EPS moved between CNY 0.77 and CNY 0.43. This gives investors a clear view of how the top and bottom lines...

Lepu Biopharma (SEHK:2157) just reported full year 2025 earnings, with sales of CN¥934.87 million and net income of CN¥261.36 million, compared with a net loss a year earlier. See our latest analysis for Lepu Biopharma. The earnings swing appears to be feeding into sentiment, with the HK$5.6 share price sitting after an 8.74% 1 day share price return, a 22.81% 30 day share price return and a 46.98% 1 year total shareholder return. This suggests that momentum has been building recently. If...

Qingci Games FY 2025 Earnings Snapshot Qingci Games (SEHK:6633) has reported FY 2025 results with first half revenue of CN¥247.18 million and basic EPS of CN¥0.10, while trailing twelve month EPS stands at CN¥0.18 as the business returns to profitability. Over recent periods the company has seen revenue move from CN¥342.62 million in 1H FY 2024 to CN¥285.34 million in 2H FY 2024 and CN¥247.18 million in 1H FY 2025, alongside net income shifting from CN¥45.06 million to CN¥6.06 million and...

Sinopharm Group (SEHK:1099) has drawn investor attention after its board proposed a final dividend of CN¥0.69 per share for 2025, totaling about CN¥2.15b, subject to approval at the June 18 AGM. See our latest analysis for Sinopharm Group. The proposed dividend comes after a period where momentum has been mixed, with a 30 day share price return showing a decline of 7.38% and a one year total shareholder return of 15.09%. This suggests recent weakness against a stronger longer term outcome. If...

MiniMax Group’s recent trading move and business snapshot MiniMax Group (SEHK:100) has drawn attention after a recent share price move, with a month return of 31.39% and 1 day and 7 day returns of 0.41% and 1.88% decline respectively. The company, founded in 2022 and based in George Town, Cayman Islands, designs and develops an artificial intelligence foundation model across text, audio, images, video, and music. See our latest analysis for MiniMax Group. MiniMax Group’s recent momentum is...

Sun Hung Kai (SEHK:86) has drawn fresh attention after reporting full year 2025 results, with revenue of HK$5,473.6 million, net income of HK$1,593.1 million and a higher total dividend compared with 2024. See our latest analysis for Sun Hung Kai. At a share price of HK$4.25, Sun Hung Kai has seen a 6.52% 90 day share price return and a 45.33% 1 year total shareholder return, which may indicate momentum around the stronger earnings and higher dividend announcement. If the earnings story here...

Assessing Xiaomi after a mixed share price run Xiaomi (SEHK:1810) has drawn fresh attention after a mixed share price stretch, with a 1.7% gain over the past day set against declines over the month and past 3 months. See our latest analysis for Xiaomi. Set against a 1-year total shareholder return decline of 35.36% and a 3-year total shareholder return above 170%, the recent negative 3-month share price return suggests momentum has cooled after a much stronger earlier period. If Xiaomi has...

The analysts might have been a bit too bullish on BOE Varitronix Limited ( HKG:710 ), given that the company fell short...

Last week, you might have seen that Beijing Enterprises Water Group Limited ( HKG:371 ) released its yearly result to...

Investors in InnoCare Pharma Limited ( HKG:9969 ) had a good week, as its shares rose 7.5% to close at HK$13.11...

Kingsoft Corporation Limited ( HKG:3888 ) last week reported its latest full-year results, which makes it a good time...

As you might know, CSPC Pharmaceutical Group Limited ( HKG:1093 ) last week released its latest annual, and things did...

Even though Chongqing Machinery & Electric Co., Ltd. ( HKG:2722 ) posted strong earnings, investors appeared to be...

There's been a notable change in appetite for Morimatsu International Holdings Company Limited ( HKG:2155 ) shares in...

Investors in Cheerwin Group Limited ( HKG:6601 ) had a good week, as its shares rose 5.1% to close at HK$2.28 following...

Akeso (SEHK:9926) has reported FY 2025 results with second half revenue of C¥1.6b and a basic EPS loss of C¥0.60, while trailing 12 month revenue reached C¥3.1b against a net loss of C¥1.1b. The business has seen revenue move from C¥1.1b in 2H 2024 to C¥1.6b in 2H 2025, with basic EPS shifting from a loss of C¥0.32 to a loss of C¥0.60 over the same period, as investors weigh growth in the top line against persistent losses. Overall, the latest numbers point to expanding operations but...

Meitu (SEHK:1357) has just posted its FY 2025 first half scorecard, with revenue of CN¥1.8b and basic EPS of CN¥0.09, against a backdrop of trailing twelve month revenue of CN¥3.5b and EPS of CN¥0.20 that coincides with earnings growth of 97.9% over the past year. The company has seen revenue move from CN¥1.6b and EPS of CN¥0.07 in 1H 2024 to CN¥1.8b and EPS of CN¥0.09 in 1H 2025, while trailing net profit margin sits at 25.4% versus 14.9% a year earlier and sets up a margin story that...